Literature DB >> 30767388

Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations.

Amy Peacock1,2, Briony Larance1,2, Raimondo Bruno1,3, Sallie-Anne Pearson4, Nicholas A Buckley5, Michael Farrell1, Louisa Degenhardt1.   

Abstract

Entities:  

Keywords:  Abuse deterrent formulation; dependence; extra-medical use; injecting; opioid; overdose; pharmacoepidemiology; post-marketing; stigma; tamper

Mesh：

Substances：

Year:  2019        PMID： 30767388      PMCID： PMC6656581          DOI： 10.1111/add.14556

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  10 in total

1.  The productive techniques and constitutive effects of 'evidence-based policy' and 'consumer participation' discourses in health policy processes.

Authors:  K Lancaster; K Seear; C Treloar; A Ritter
Journal:  Soc Sci Med       Date:  2017-01-22       Impact factor: 4.634

2.  Evaluating dynamic impacts of abuse-deterrent prescription opioid formulations.

Authors:  Keith Humphreys
Journal:  Addiction       Date:  2018-10-31       Impact factor: 6.526

3.  Are abuse-deterrent opioid formulations all they are crushed up to be?

Authors:  Lewis S Nelson
Journal:  Addiction       Date:  2018-11-05       Impact factor: 6.526

4.  Opioid Crisis: No Easy Fix to Its Social and Economic Determinants.

Authors:  Nabarun Dasgupta; Leo Beletsky; Daniel Ciccarone
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308

5.  Strategies for Reducing Opioid-Overdose Deaths - Lessons from Canada.

Authors:  Evan Wood
Journal:  N Engl J Med       Date:  2018-04-26       Impact factor: 91.245

6.  Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis.

Authors:  Alexandra B Collins; Ricky N Bluthenthal; Jade Boyd; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2018-03-20

7.  Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting.

Authors:  Amy Peacock; Briony Larance; Raimondo Bruno; Sallie-Anne Pearson; Nicholas A Buckley; Michael Farrell; Louisa Degenhardt
Journal:  Addiction       Date:  2018-09-07       Impact factor: 6.526

Review 8.  Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours.

Authors:  Briony Larance; Louisa Degenhardt; Nick Lintzeris; Adam Winstock; Richard Mattick
Journal:  Drug Alcohol Rev       Date:  2011-05

9.  The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study.

Authors:  Briony Larance; Timothy Dobbins; Amy Peacock; Robert Ali; Raimondo Bruno; Nicholas Lintzeris; Michael Farrell; Louisa Degenhardt
Journal:  Lancet Psychiatry       Date:  2018-01-11       Impact factor: 27.083

Review 10.  Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.

Authors:  Kevin E Vowles; Mindy L McEntee; Peter Siyahhan Julnes; Tessa Frohe; John P Ney; David N van der Goes
Journal:  Pain       Date:  2015-04       Impact factor: 6.961
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.